Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia. - Wikidata - awgldk - TriplyDB

Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia.

Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia.

http://www.wikidata.org/entity/Q30252929

about

Analysis of mammalian O-glycopeptides - we have made a good start, but there is a long way to go.The Role of Electron Transfer Dissociation in Modern Proteomics.Crystal structures of H-2Db in complex with the LCMV-derived peptides GP92 and GP392 explain pleiotropic effects of glycosylation on antigen presentation and immunogenicity.The role of mass spectrometry and proteogenomics in the advancement of HLA epitope prediction.Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase.Current Strategies to Enhance Anti-Tumour Immunity.Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry

P2860

Q46846034-1DD24765-74CE-4A23-B450-C8460A87DE86 Q47111216-F1D2C905-C221-4B50-869A-1962DAEC0C6E Q47144276-C2CF81B8-E7AB-4589-90D8-EA74D88B2ABF Q47190955-ABB0D975-BD33-44E9-8D12-7661350EC952 Q47617036-1843B930-8070-454E-95A9-D0B6EE48F03E Q52344613-733CDD63-A6F9-4323-9B61-22F7B1D326E5 Q57178228-723C4F55-7C13-4792-9D54-F49B45A0C05C

P2860

Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia.

http://www.wikidata.org/entity/Q30252929

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia.

@ast

Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia.

@en

type

label

Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia.

@ast

Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia.

@en

prefLabel

Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia.

@ast

Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia.

@en

P1433

Q30252929-8486897E-70D2-4E8B-9C56-7D13889B0319

P1476

Q30252929-2A388137-D741-434F-91B8-A3A999A288E8

P2093

Q30252929-1ABAC117-FACC-4E4A-A191-8472D61A76B5

Q30252929-578338FC-B711-44D2-A983-7270993DF5E9

Q30252929-6418D469-1730-4901-A1E3-3F584AA3620A

Q30252929-742315A9-145E-4ABB-ACB0-E27C3A8E347A

Q30252929-97028123-C3EF-462F-87C7-DB55E1955D9F

Q30252929-C811D989-E711-4EB2-8AAA-4E8AF0646F76

Q30252929-E2BFD6F0-3CE3-48E8-B055-DF0F89247F7B

Q30252929-E35BDD73-B5B9-4C9A-9A21-E59FF5802B95

P2860

Q30252929-0DEEB298-D75E-4970-AF88-65F5685699E2

Q30252929-0E7A6BD9-57D5-4049-85E8-08830A7735E0

Q30252929-202C4505-A428-44B2-A1A3-640FEF5F9DF9

Q30252929-22AFE671-7E17-4316-9816-A044DE27A45C

Q30252929-231F473C-7C93-4ADA-B738-F538349FE427

Q30252929-25FD2162-7D2E-42E3-9A6A-BDFD38A53E6E

Q30252929-2D653F41-CAF8-4285-A99A-0C0F20374FE8

Q30252929-33589A00-5049-4604-9437-DBDDE2F23BDB

Q30252929-389CF055-4522-49F3-A24E-9F1C090235BB

Q30252929-394E915F-B1B8-493D-B4ED-69E4BD306FF8

P304

Q30252929-EF3F3917-D7CB-48A2-9613-744DF59A4454

P31

Q30252929-4F6CE12F-4354-433B-8614-EEC79B0DDC4C

P356

Q30252929-25C91AA9-39FC-492C-A227-ED01214E1C4A

P433

Q30252929-86AF9263-1AA7-4E82-A3A6-D7EB670EA936

P478

Q30252929-B3D1E37F-98FA-4D6D-880E-7323997F779F

P50

Q30252929-013151AC-0548-4BD1-9DA0-96F22A5C78BA

Q30252929-E921EEDF-2313-4E8B-8087-DA546D1375DF

P577

Q30252929-0767F744-18D3-41FB-BB61-A0BFEB0CDC17

P698

Q30252929-E5CF4F63-A173-4B81-BF7C-956275856C91

P921

Q30252929-39BF99E7-81D6-4E00-8E02-490124B04791

P932

Q30252929-46CDC22F-6F5E-4700-B406-86646020044A

P356

2326-6066.CIR-16-0280

P1433

Cancer immunology research

P1476

Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia.

@en

P2093

Dina L Bai

http://www.w3.org/2001/XMLSchema#string

Donald F Hunt

http://www.w3.org/2001/XMLSchema#string

Jeffrey Shabanowitz

http://www.w3.org/2001/XMLSchema#string

Justin C Loke

http://www.w3.org/2001/XMLSchema#string

Lora G Steadman

http://www.w3.org/2001/XMLSchema#string

Mark Cobbold

http://www.w3.org/2001/XMLSchema#string

Paisley T Myers

http://www.w3.org/2001/XMLSchema#string

Sarah A Penny

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity

Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

Genetic basis for clinical response to CTLA-4 blockade in melanoma

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

The cytoplasmic peptide:N-glycanase (NGLY1) - Structure, expression and cellular functions

MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia.

P304

376-384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/2326-6066.CIR-16-0280

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Stacy A Malaker

P577

2017-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28314751

http://www.w3.org/2001/XMLSchema#string

P921

P932

5508727

http://www.w3.org/2001/XMLSchema#string